Natural History of the Post-ablation Esophagus
- 18 April 2018
- journal article
- review article
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 63 (8) , 2136-2145
Abstract
Endoscopic ablative therapy including radiofrequency ablation (RFA) represents the preferred management strategy for dysplastic Barrett’s esophagus (BE) and appears to diminish the risk of developing esophageal adenocarcinoma (EAC). Limited data describe the natural history of the post-ablation esophagus. Recent findings demonstrate that recurrent intestinal metaplasia (IM) following RFA is relatively frequent. However, dysplastic BE and EAC subsequent to the complete eradication of intestinal metaplasia (CEIM) are uncommon. Moreover, data suggest that the risk of recurrent disease is probably highest in the first year following CEIM. Recurrent IM and dysplasia are usually successfully eradicated with repeat RFA. Future studies may refine surveillance intervals and inform the length of time surveillance should be conducted following RFA with CEIM. Further data will also be necessary to understand the utility of chemopreventive strategies, including NSAIDs, in reducing the risk of recurrent disease.Keywords
This publication has 47 references indexed in Scilit:
- Persistence of Nondysplastic Barrett's Esophagus Identifies Patients at Lower Risk for Esophageal Adenocarcinoma: Results From a Large Multicenter CohortGastroenterology, 2013
- Characterization of buried glands before and after radiofrequency ablation by using 3-dimensional optical coherence tomography (with videos)Gastrointestinal Endoscopy, 2012
- Nonsteroidal Anti-inflammatory Drug Use Reduces Risk of Adenocarcinomas of the Esophagus and Esophagogastric Junction in a Pooled AnalysisGastroenterology, 2012
- Safety of Prior Endoscopic Mucosal Resection in Patients Receiving Radiofrequency Ablation of Barrett's EsophagusClinical Gastroenterology and Hepatology, 2012
- Adequacy of esophageal squamous mucosa specimens obtained during endoscopy: are standard biopsies sufficient for postablation surveillance in Barrett's esophagus?Gastrointestinal Endoscopy, 2012
- Buried Metaplasia After Endoscopic Ablation of Barrett's Esophagus: A Systematic ReviewAmerican Journal of Gastroenterology, 2011
- Durability of Radiofrequency Ablation in Barrett's Esophagus With DysplasiaGastroenterology, 2011
- Detection of Intestinal Metaplasia After Successful Eradication of Barrett’s Esophagus with Radiofrequency AblationDigestive Diseases and Sciences, 2011
- Biopsy depth after radiofrequency ablation of dysplastic Barrett's esophagusGastrointestinal Endoscopy, 2010
- Improving surveillance for Barrett's oesophagusBMJ, 2006